ImmuCell - 38 Year Stock Price History | ICCC
Historical daily share price chart and data for ImmuCell since 1987 adjusted for splits and dividends. The latest closing stock price for ImmuCell as of August 12, 2025 is 6.65.
- The all-time high ImmuCell stock closing price was 18.75 on June 26, 1987.
- The ImmuCell 52-week high stock price is 7.60, which is 14.3% above the current share price.
- The ImmuCell 52-week low stock price is 3.34, which is 49.8% below the current share price.
- The average ImmuCell stock price for the last 52 weeks is 4.99.
| ImmuCell Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2025 | 5.6898 | 5.2200 | 7.6000 | 4.7800 | 6.6500 | 29.13% |
| 2024 | 4.4496 | 5.0000 | 5.4765 | 3.5300 | 5.1500 | 1.18% |
| 2023 | 5.3818 | 6.4800 | 7.8400 | 4.4500 | 5.0900 | -16.56% |
| 2022 | 8.1677 | 8.1907 | 10.7100 | 6.0930 | 6.1000 | -23.75% |
| 2021 | 9.3799 | 6.0988 | 11.8800 | 5.9800 | 8.0001 | 34.46% |
| 2020 | 5.1673 | 5.1500 | 6.4235 | 3.7900 | 5.9500 | 15.53% |
| 2019 | 6.0824 | 7.0400 | 8.0900 | 4.8100 | 5.1500 | -26.91% |
| 2018 | 7.3523 | 8.2700 | 9.0300 | 6.4000 | 7.0465 | -19.84% |
| 2017 | 6.6185 | 5.9500 | 9.2300 | 5.2600 | 8.7900 | 47.73% |
| 2016 | 6.6989 | 7.4300 | 8.2100 | 4.9000 | 5.9500 | -21.09% |
| 2015 | 7.1168 | 5.1200 | 11.0500 | 5.0200 | 7.5400 | 55.14% |
| 2014 | 4.5247 | 4.2500 | 5.4500 | 3.4400 | 4.8600 | 13.84% |
| 2013 | 3.9072 | 4.1520 | 4.9400 | 3.2800 | 4.2690 | 6.72% |
| 2012 | 5.1296 | 4.8000 | 6.7500 | 3.7840 | 4.0001 | -13.98% |
| 2011 | 5.1112 | 3.2000 | 8.3400 | 3.0200 | 4.6500 | 45.31% |
| 2010 | 3.4186 | 3.6500 | 4.3900 | 2.7100 | 3.2001 | -13.74% |
| 2009 | 2.6659 | 1.7000 | 4.2299 | 1.3800 | 3.7100 | 123.48% |
| 2008 | 2.9463 | 3.5000 | 4.0000 | 1.6500 | 1.6601 | -53.24% |
| 2007 | 4.8636 | 5.9800 | 6.2300 | 3.2700 | 3.5500 | -40.34% |
| 2006 | 5.4822 | 5.1024 | 7.1500 | 4.5700 | 5.9500 | 13.33% |
| 2005 | 4.7373 | 6.6563 | 6.6563 | 3.9100 | 5.2500 | -26.68% |
| 2004 | 4.3982 | 4.0300 | 9.3900 | 3.7000 | 7.1600 | 85.06% |
| 2003 | 2.5710 | 1.7410 | 4.0800 | 1.7410 | 3.8690 | 130.30% |
| 2002 | 2.5673 | 3.6000 | 3.6500 | 1.6000 | 1.6800 | -53.97% |
| 2001 | 2.8109 | 1.7500 | 4.7400 | 1.7500 | 3.6500 | 133.60% |
| 2000 | 3.3841 | 2.5625 | 8.5000 | 1.5000 | 1.5625 | -34.21% |
| 1999 | 1.4951 | 1.2500 | 2.5000 | 1.0625 | 2.3750 | 90.00% |
| 1998 | 1.9443 | 2.5000 | 2.6250 | 1.1250 | 1.2500 | -49.37% |
| 1997 | 2.5994 | 2.3750 | 3.2500 | 2.0625 | 2.4688 | 3.95% |
| 1996 | 3.1720 | 2.3750 | 5.5000 | 2.0625 | 2.3750 | -2.56% |
| 1995 | 1.8334 | 1.1250 | 2.6563 | 1.0313 | 2.4375 | 129.41% |
| 1994 | 1.7521 | 2.0000 | 2.3750 | 1.0000 | 1.0625 | -44.26% |
| 1993 | 1.4814 | 1.3125 | 2.1250 | 1.0000 | 1.9063 | 45.24% |
| 1992 | 1.3622 | 0.6875 | 2.4070 | 0.6875 | 1.3125 | 90.91% |
| 1991 | 0.8776 | 0.5625 | 1.4688 | 0.4219 | 0.6875 | 22.22% |
| 1990 | 3.6261 | 7.9000 | 7.9000 | 0.5469 | 0.5625 | -92.88% |
| 1989 | 9.0608 | 11.0000 | 12.5000 | 6.2500 | 7.9000 | -28.18% |
| 1988 | 12.5073 | 6.2500 | 15.7000 | 6.2500 | 11.0000 | 76.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.060B | $0.026B |
| ImmuCell Corp. is a biotechnology company striving to build shareholder value by commercializing proprietary technologies and helping dairy and beef producers and their veterinarians manage disease and reproduction in their herds. The company is also conducting an open label, efficacy study of DiffGAM, a human application of its milk-derived passive antibodytechnology for use as an alternative to antibiotics in the treatment and/or prevention of Clostridium difficile-associated diarrhea. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $228.627B | 26.81 |
| Boston Scientific (BSX) | United States | $152.250B | 36.31 |
| Stryker (SYK) | United States | $144.004B | 29.31 |
| EssilorLuxottica (ESLOY) | France | $135.646B | 0.00 |
| Medtronic (MDT) | Ireland | $118.875B | 16.86 |
| Lonza Group Ag (LZAGY) | Switzerland | $46.688B | 0.00 |
| Haleon (HLN) | United Kingdom | $42.538B | 24.28 |
| ResMed (RMD) | United States | $41.629B | 29.77 |
| GE HealthCare Technologies (GEHC) | United States | $33.329B | 15.66 |
| Agilent Technologies (A) | United States | $32.420B | 21.14 |
| Terumo (TRUMY) | Japan | $27.464B | 32.54 |
| Koninklijke Philips (PHG) | Netherlands | $25.691B | 16.99 |
| Insulet (PODD) | United States | $21.458B | 71.90 |
| Zimmer Biomet Holdings (ZBH) | United States | $19.814B | 12.61 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $15.750B | 0.00 |
| Baxter (BAX) | United States | $12.050B | 9.31 |
| Sunny Optical Technology (SNPTF) | China | $10.417B | 0.00 |
| Demant (WILYY) | Denmark | $8.599B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.159B | 26.30 |
| Lantheus Holdings (LNTH) | United States | $3.812B | 10.31 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.350B | 23.44 |
| Prestige Consumer Healthcare (PBH) | United States | $3.144B | 13.95 |
| Perrigo (PRGO) | Ireland | $3.030B | 7.57 |
| ICU Medical (ICUI) | United States | $2.669B | 18.17 |
| Haemonetics (HAE) | United States | $2.528B | 11.28 |
| LeMaitre Vascular (LMAT) | United States | $2.097B | 44.96 |
| Curaleaf Holdings (CURLF) | Canada | $1.850B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.800B | 77.27 |
| AtriCure (ATRC) | United States | $1.764B | 0.00 |
| QuidelOrtho (QDEL) | United States | $1.605B | 10.10 |
| AdaptHealth (AHCO) | United States | $1.259B | 17.94 |
| Phibro Animal Health (PAHC) | United States | $1.157B | 14.79 |
| Acuren (TIC) | United States | $1.119B | 0.00 |
| Neogen (NEOG) | United States | $1.110B | 17.62 |
| BioLife Solutions (BLFS) | United States | $1.072B | 2237.00 |
| Tilray Brands (TLRY) | Canada | $1.012B | 0.00 |
| InMode (INMD) | Israel | $0.872B | 8.07 |
| Kestra Medical Technologies (KMTS) | United States | $0.752B | 0.00 |
| Valneva SE (VALN) | France | $0.723B | 0.00 |
| Surmodics (SRDX) | United States | $0.543B | 0.00 |
| ZimVie (ZIMV) | United States | $0.531B | 20.47 |
| SNDL (SNDL) | Canada | $0.528B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.525B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.486B | 0.00 |
| CeriBell (CBLL) | United States | $0.444B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.434B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.405B | 13.96 |
| Evolus (EOLS) | United States | $0.373B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.366B | 0.00 |
| Owens & Minor (OMI) | United States | $0.358B | 3.17 |
| Capricor Therapeutics (CAPR) | United States | $0.357B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.330B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.324B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.294B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.283B | 21.44 |
| Omeros (OMER) | United States | $0.256B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.251B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.239B | 0.00 |
| Cerus (CERS) | United States | $0.239B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.230B | 0.00 |
| Brainsway (BWAY) | Israel | $0.229B | 60.50 |
| Organigram Global (OGI) | Canada | $0.220B | 0.00 |
| Quanterix (QTRX) | United States | $0.213B | 0.00 |
| Exagen (XGN) | United States | $0.206B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.204B | 0.00 |
| High Tide (HITI) | Canada | $0.194B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.183B | 15.04 |
| Jushi Holdings (JUSHF) | United States | $0.157B | 0.00 |
| Biote (BTMD) | United States | $0.154B | 4.62 |
| FitLife Brands (FTLF) | United States | $0.147B | 18.07 |
| TriSalus Life Sciences (TLSI) | United States | $0.135B | 0.00 |
| Jin Medical (ZJYL) | China | $0.102B | 0.00 |
| Fonar (FONR) | United States | $0.094B | 12.16 |
| MacroGenics (MGNX) | United States | $0.093B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.092B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.085B | 0.00 |
| Apyx Medical (APYX) | United States | $0.084B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.075B | 0.00 |
| Agape ATP (ATPC) | $0.068B | 0.00 | |
| Safety Shot (SHOT) | United States | $0.068B | 0.00 |
| Veru (VERU) | United States | $0.053B | 0.00 |
| Nephros (NEPH) | United States | $0.048B | 37.42 |
| Zynex (ZYXI) | United States | $0.043B | 0.00 |
| Modular Medical (MODD) | United States | $0.039B | 0.00 |
| United-Guardian (UG) | United States | $0.036B | 14.02 |
| Rockwell Medical (RMTI) | United States | $0.032B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.019B | 0.00 |
| INLIF (INLF) | $0.016B | 0.00 | |
| Trinity Biotech (TRIB) | Ireland | $0.015B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Flora Growth (FLGC) | United States | $0.012B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.012B | 0.00 |
| Senestech (SNES) | United States | $0.010B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.009B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.008B | 0.00 |
| Sharps Technology (STSS) | United States | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |